Merck opens meglumine production facility in Mollet del Vallès, Spain

Merck announced the opening of a facility in Mollet del Vallès, Spain, dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.

“Merck today announced the opening of a facility in Mollet des Valles, Spain dedicated to the manufacture of meglumine.”kyodonewsprwire.jp

• 1 source
• kyodonewsprwire.jpメルクがスペインにメグルミン専用の製造施設を開設 | Merckのプレスリリース | 共同通信PRワイヤー株式会社共同通信社 ジャパンビジネス広報センターJan 18, 2017

Summarized from public sources; check the original articles before acting on it.